SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-056413
Filing Date
2021-11-12
Accepted
2021-11-12 06:32:56
Documents
14
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR Q3'21 EARNINGS RELEASE eldn-8k_20211111.htm   iXBRL 8-K 44838
2 EX-99.1 eldn-ex991_8.htm EX-99.1 262144
3 GRAPHIC g1ur0exdnh4x000001.jpg GRAPHIC 7626
  Complete submission text file 0001564590-21-056413.txt   460665

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eldn-20211111.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eldn-20211111_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eldn-20211111_pre.xml EX-101.PRE 11624
7 EXTRACTED XBRL INSTANCE DOCUMENT eldn-8k_20211111_htm.xml XML 3551
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 211399293
SIC: 2834 Pharmaceutical Preparations